Can genes predict pancreatic tumor risk? new study aims to find out
NCT ID NCT05746182
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the genes of 300 people with pancreatic neuroendocrine tumors to find inherited mutations that may be linked to the disease. Participants provide a blood or saliva sample for genetic testing. The goal is to learn more about genetic causes, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC NEUROENDOCRINE NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Univeristy of California, San Diego
RECRUITINGSan Diego, California, 92093, United States
Contact
-
University of California, Los Angeles
RECRUITINGLos Angeles, California, 90095, United States
Contact
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94143, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.